Feasibility and effectiveness of afatinib for poor performance status patients with EGFR-mutation-positive non-small-cell lung cancer: a retrospective cohort study

Overview of attention for article published in BMC Cancer, July 2021

Altmetric Badge

About this Attention Score

So far, Altmetric has seen 2 X posts from 1 X users, with an upper bound of 906 followers.

New article: Feasibility and effectiveness of afatinib for poor performance status patients with EGFR-mutation-positive non-small-cell lung cancer: a retrospective cohort study https://t.co/DHC57XDL57 #livercancer #oncology https://t.co/No1pG6c5Uo

New article: Feasibility and effectiveness of afatinib for poor performance status patients with EGFR-mutation-positive non-small-cell lung cancer: a retrospective cohort study https://t.co/sboK4kM860 #lungcancer #oncology https://t.co/4jD00I0SOE

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.